The Patent Finder

bioMérieux, Inc.

Also on record
Records under this name other than patents bioMérieux, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to bioMérieux, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,503,736Antibodies to crosslinkers and methods for using the same
Term ended
Term ended Nov 12, 2019 · USPTO record
Term endedTerm ended Nov 12, 2019USPTO record
US 6,596,532Device for isolation and surface culture of microorganisms from bulk fluids
Term ended
Ended no later than Dec 12, 2017 · USPTO record
Term endedEnded no later than Dec 12, 2017USPTO record
US 6,429,007Nucleic acid amplification reaction station for disposable test devices
Term ended
Ended no later than May 2, 2017 · USPTO record
Term endedEnded no later than May 2, 2017USPTO record
US 6,548,631Macrophage derived chemokine (MDC) as an anti-viral agent for the treatment and prevention of lentivirus infection
Lapsed on the fee record
Ended Apr 15, 2015 · USPTO record
Lapsed on the fee recordEnded Apr 15, 2015USPTO record
US 6,465,172HIV Immunogenic Complexes Comprising GP120 Covalently Bound to CD4 or Concanavalin A
Lapsed on the fee record
Ended Oct 15, 2006 · Medium confidence
Lapsed on the fee recordEnded Oct 15, 2006Medium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited